Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Travoprost Intraocular Implant + iStent Infinite

NCT: NCT06066645 · RECRUITING

NCT IDNCT06066645
StatusRECRUITING
Start Date2023-09-14
SponsorGlaukos Corporation (INDUSTRY)
First posted
Last updated

Brief Summary

Adult subjects with elevated intraocular pressure will be randomized to receive iStent infinite trabecular bypass system plus a travoprost intraocular implant or receive a sham procedure plus a travoprost intraocular implant and be followed for 12 months.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑